Total Payments
$2,674
2024 Payments
$915.31
Companies
26
Transactions
130
Payment Breakdown by Category
Food & Beverage$2,674 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,674 | 130 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $445.98 | 23 | $0 (2024) |
| Novo Nordisk Inc | $428.72 | 15 | $0 (2024) |
| ITI, Inc. | $321.63 | 11 | $0 (2023) |
| GlaxoSmithKline, LLC. | $211.81 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $172.08 | 8 | $0 (2024) |
| Lilly USA, LLC | $148.90 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $104.86 | 7 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $102.43 | 7 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $94.29 | 1 | $0 (2024) |
| PFIZER INC. | $90.33 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $915.31 | 39 | Novo Nordisk Inc ($204.08) |
| 2023 | $748.32 | 31 | Novo Nordisk Inc ($181.44) |
| 2022 | $512.26 | 28 | ITI, Inc. ($158.47) |
| 2021 | $498.55 | 32 | AbbVie Inc. ($117.86) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: PAIN | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Biological | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.80 | General |
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.38 | General |
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: PAIN | ||||||
| 06/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: GASTROENTEROLOGY | ||||||
About Brett Duplantis, PAC
Brett Duplantis, PAC is a Physician Assistant healthcare provider based in Cut Off, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073660676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brett Duplantis, PAC has received a total of $2,674 in payments from pharmaceutical and medical device companies, with $915.31 received in 2024. These payments were reported across 130 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,674).
Ad
Practice Information
- Specialty Physician Assistant
- Location Cut Off, LA
- Active Since 01/04/2007
- Last Updated 08/21/2015
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1073660676
Products in Payments
- CAPLYTA (Drug) $415.92
- Wegovy (Drug) $267.70
- UBRELVY (Drug) $224.82
- TRELEGY ELLIPTA (Drug) $211.81
- VRAYLAR (Drug) $186.05
- NURTEC ODT (Drug) $146.88
- MOUNJARO (Drug) $105.59
- XIFAXAN (Drug) $104.86
- FARXIGA (Drug) $93.64
- Kerendia (Drug) $78.71
- Ozempic (Drug) $77.50
- Cologuard Collection Kit (Device) $71.94
- Veozah (Drug) $55.71
- Aimovig (Biological) $53.02
- ELIQUIS (Drug) $50.41
- Austedo XR (Drug) $49.41
- AUSTEDO (Drug) $39.21
- Saxenda (Drug) $37.06
- QULIPTA (Drug) $35.11
- ARISTADA (Drug) $34.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.